BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 2.84 Billion SEK | 129.16% |
| 2021 | 1.24 Billion SEK | 441.13% |
| 2020 | 229.7 Million SEK | 135.43% |
| 2019 | 97.56 Million SEK | 142.26% |
| 2018 | 40.27 Million SEK | 230.52% |
| 2017 | 12.18 Million SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 559.3 Million SEK | 13.63% |
| 2023 Q3 | 491.9 Million SEK | -12.05% |
| 2023 Q1 | 492.2 Million SEK | -60.77% |
| 2022 Q3 | 538.9 Million SEK | -6.75% |
| 2022 Q2 | 577.9 Million SEK | 21.18% |
| 2022 Q1 | 476.9 Million SEK | 3.58% |
| 2022 FY | 2.84 Billion SEK | 129.16% |
| 2022 Q4 | 1.25 Billion SEK | 132.83% |
| 2021 FY | 1.24 Billion SEK | 441.13% |
| 2021 Q2 | 260.1 Million SEK | 46.95% |
| 2021 Q3 | 345.5 Million SEK | 32.83% |
| 2021 Q4 | 460.4 Million SEK | 33.26% |
| 2021 Q1 | 177 Million SEK | 0.0% |
| 2020 Q1 | 60.49 Million SEK | 21.26% |
| 2020 FY | 229.7 Million SEK | 135.43% |
| 2020 Q2 | 55.89 Million SEK | -7.6% |
| 2020 Q3 | 63.41 Million SEK | 13.44% |
| 2019 Q1 | 18.58 Million SEK | 2.5% |
| 2019 FY | 97.56 Million SEK | 142.26% |
| 2019 Q2 | 25.81 Million SEK | 38.86% |
| 2019 Q4 | 49.89 Million SEK | 53.04% |
| 2019 Q3 | 32.6 Million SEK | 26.31% |
| 2018 Q4 | 18.13 Million SEK | -2.45% |
| 2018 FY | 40.27 Million SEK | 230.52% |
| 2018 Q1 | 6.07 Million SEK | 7.13% |
| 2018 Q2 | 8.93 Million SEK | 47.13% |
| 2018 Q3 | 18.58 Million SEK | 108.12% |
| 2017 Q2 | 3.65 Million SEK | 48.72% |
| 2017 FY | 12.18 Million SEK | 0.0% |
| 2017 Q1 | 2.45 Million SEK | 70.6% |
| 2017 Q4 | 5.66 Million SEK | 22.4% |
| 2017 Q3 | 4.63 Million SEK | 26.61% |
| 2016 Q4 | 1.44 Million SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acarix AB (publ) | 82.85 Million SEK | -3338.021% |
| ADDvise Group AB (publ) | 611.8 Million SEK | -365.577% |
| ADDvise Group AB (publ) | 611.8 Million SEK | -365.577% |
| Arcoma AB | 53.25 Million SEK | -5248.907% |
| Bactiguard Holding AB (publ) | 4.96 Million SEK | -57223.405% |
| Boule Diagnostics AB (publ) | 210.44 Million SEK | -1253.519% |
| CellaVision AB (publ) | 295.99 Million SEK | -862.33% |
| Clinical Laserthermia Systems AB (publ) | 68.93 Million SEK | -4032.308% |
| Chordate Medical Holding AB (publ) | 1.3 Million SEK | -217470.806% |
| C-Rad AB (publ) | 3.8 Million SEK | -74857.895% |
| Duearity AB (publ) | 21.58 Million SEK | -13096.201% |
| Dignitana AB (publ) | 74.73 Million SEK | -3711.282% |
| Episurf Medical AB (publ) | 2.7 Million SEK | -105396.296% |
| Getinge AB (publ) | 10.75 Billion SEK | 73.525% |
| Scandinavian Real Heart AB (Publ) | 18.22 Million SEK | -15526.029% |
| Iconovo AB (publ) | 63.35 Million SEK | -4395.977% |
| Integrum AB (publ) | 90.57 Million SEK | -3044.918% |
| Luxbright AB (publ) | 23.09 Million SEK | -12235.799% |
| Mentice AB (publ) | 237.06 Million SEK | -1101.552% |
| OssDsign AB (publ) | 175.6 Million SEK | -1522.086% |
| Paxman AB (publ) | 133.8 Million SEK | -2028.849% |
| Promimic AB (publ) | 48.55 Million SEK | -5766.7% |
| Qlife Holding AB (publ) | 162.38 Million SEK | -1654.103% |
| SciBase Holding AB (publ) | 69.97 Million SEK | -3970.538% |
| ScandiDos AB (publ) | 61.03 Million SEK | -4566.601% |
| Sectra AB (publ) | 39.06 Million SEK | -7191.811% |
| Sedana Medical AB (publ) | 174.52 Million SEK | -1532.059% |
| Senzime AB (publ) | 141.51 Million SEK | -1912.762% |
| SpectraCure AB (publ) | 12.12 Million SEK | -23386.148% |
| Stille AB | 87.21 Million SEK | -3165.802% |
| Vitrolife AB (publ) | 5.56 Billion SEK | 48.834% |
| Xvivo Perfusion AB (publ) | 440.92 Million SEK | -546.007% |